Our February webinar featured Timothy Ziemlewicz, M.D. from the University of Wisconsin presenting:
"Clinical Experience with Histotripsy"
This session was moderated by George R. Schade, M.D. from the University of Washington.
University of Wisconsin
Dr. Ziemlewicz is a Professor of Radiology in the section of Abdominal Imaging and Intervention at the University of Wisconsin. He serves as an assistant residency program director, chairs the programs clinical competency committee, and is the medical director of ultrasound. He joined the faculty in 2010 following the completion of an abdominal imaging fellowship at Duke University and diagnostic radiology residency at Wayne State University, Detroit, MI. He spent the early part of his career with a clinical and research focus on thermal tumor ablation and image post-processing for surgical planning. In recent years he has worked closely with the scientists and clinicians who pioneered histotripsy to help advance the technique to clinical adoption. His NIH and industry funded research lab is focused on clinical translation of histotripsy, thermal ablation, and the use of ultrasound for intervention. He has been involved in numerous multi-center clinical trials for thermal ablation and histotripsy, including serving as the co-PI of the #HOPE4LIVER trial which lead to the FDA approval of histotripsy for the treatment of hepatic tumors. In addition to his active thermal ablation and histotripsy practice, he currently educates new users of histotripsy and advises for ongoing clinical trials in the space.
About the Moderator
University of Washington
George R. Schade, MD is an Associate Professor of Urology at the University of Washington. He completed his undergraduate and medical education at the University of Chicago, his Urology Residency at the University of Michigan, and SUO fellowship at the University of Washington. During his residency and fellowship he completed post-doctoral research training in the field of historipsy with Will Roberts, MD and Vera Khohklova, PhD. As a clinician-scientist he leads an R01 funded translational science program aimed at developing therapeutic ultrasound and imaging applications, with emphasis on histotripsy, to reduce the burden of cancer on patients and improve their quality of life. He is the director of the UW Prostate Cancer Focal Therapy Program and member of the West Coast Focal Therapy Collaborative. He is an active user of clinically available therapeutic ultrasound systems using HIFU to treat prostate cancer and investigate clinical outcomes of HIFU. Additionally, he is an active educator training the next generation of clinicians on the benefits of, indications for, and how to perform HIFU. He has been an active participant in ISTU for >10 years and is serving his second term on the ISTU board.